CLINICAL, PARACLINICAL AND MAGNETIC RESONANCE IMAGING FEATURES\IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA UNDERGOING PROSTATIC ARTERY EMBOLIZATION

Trịnh Tú Tâm1,, Nguyễn Hoàng Thịnh1, Nguyễn Quốc Dũng1, Nguyễn Xuân Hiền2
1 Friendship Hospital
2 Medical Imaging Center, Tâm Anh Hospital

Main Article Content

Abstract

Objectives: To describe the clinical, paraclinical and magnetic resonance imaging characteristics of patients with benign prostatic hyperplasia undergoing prostatic artery embolization. Subjects and research methods: A retrospective study was performed on 66 patients with benign prostatic hyperplasia who underwent prostatic artery embolectomy at Huu Nghi Hospital from May 2015 to June 2019. Describe clinical, paraclinical and magnetic resonance images before intervention. Results: From May 2015 to June 2019, there were 66 patients with mean age 73.58±7.9 years, mean prostate volume 62.8±29.86 mL, mean PSA concentration 10±18.57 ng/mL. All patients had severe lower urinary tract syndrome (IPSS > 20 points), of which the highest percentage was score > 30 with 59.1%; Urinary incontinence is the symptom with the highest frequency with the rate of 92.4%, followed by the symptoms of intermittent urination 72.7% and weak urine stream 66.7%. The most common form of prostate morphological change on magnetic resonance imaging according to Wasserman's classification was type 1 (28.8%) and type 3 (37.9%), none of which were classified as type 4. Benign prostatic hyperplasia with protrusion into the bladder was mainly seen in type 5 with 14/23 cases. Among the cases with protrusion into the bladder, grade 3 (>10mm) accounted for the majority with the rate of 69.6%. Conclusion: Selection of patients for prostatic artery embolization depends on many factors including clinical symptoms and biochemical as well as diagnostic imaging with the aim of accurately assessing disease status. In which, magnetic resonance is a valuable imaging method to evaluate the volume, morphology, and properties of the pre-interventional parenchyma.

Article Details

References

1. Garraway, W.M., G.N. Collins, and R.J. Lee, High prevalence of benign prostatic hypertrophy in the community. Lancet, 1991. 338(8765): p. 469-71.
2. Kirkham, A.P., et al., Prostate MRI: who, when, and how? Report from a UK consensus meeting. Clin Radiol, 2013. 68(10): p. 1016-23.
3. Wasserman, N.F., et al., Use of MRI for Lobar Classification of Benign Prostatic Hyperplasia: Potential Phenotypic Biomarkers for Research on Treatment Strategies. AJR Am J Roentgenol, 2015. 205(3): p. 564-71.
4. Dmochowski, R.R., Bladder outlet obstruction: etiology and evaluation. Rev Urol, 2005. 7 Suppl 6: p. S3-S13.
5. Shapiro, E., et al., The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic benign prostate hyperplasia. J Urol, 1992. 147(5): p. 1293-7.
6. Hansford, B.G., et al., Dynamic contrast-enhanced MR imaging features of the normal central zone of the prostate. Acad Radiol, 2014. 21(5): p. 569-77.
7. Shin, S.H., et al., Defining the degree of intravesical prostatic protrusion in association with bladder outlet obstruction. Korean J Urol, 2013. 54(6): p. 369-72.
8. Topazio, L., et al., Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study. BMC Urol, 2018. 18(1): p. 6.